• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
48,502.41 -615.65
(-1.25%)
Dow Jones
6,987.82 -209.01
(-2.90%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.34 -0.08
(-0.09%)
EUR-INR
102.47 -0.06
(-0.06%)
GBP-INR
122.55 -0.48
(-0.39%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
511.5350455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
29.99
16026.92
EPS(TTM)
Face Value()
Div & Yield %
27.24
2
0.56
 

radhagobind commercial ltd
Dr Reddy's Laboratories consolidated net profit declines 31.35% in the September 2026 quarter
Oct 24,2026
Net profit of Dr Reddy's Laboratories declined 31.35% to Rs 924.80 crore in the quarter ended September 2026 as against Rs 1347.10 crore during the previous quarter ended September 2025. Sales declined 1.52% to Rs 8670.80 crore in the quarter ended September 2026 as against Rs 8804.90 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales8670.808804.90 -2
OPM %19.8722.83 -
PBDT1754.302249.40 -22
PBT1227.601744.80 -30
NP924.801347.10 -31